Brief: XORTX Opens An Ind For Xrx-008 Program For Autosomal Dominant Polycystic Kidney Disease
05/05/2022 12:26
May 5 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX OPENS AN IND FOR XRX-008 PROGRAM FOR AUTOSOMAL
DOMINANT
POLYCYSTIC KIDNEY DISEASE
Source text for Eikon: ID:nGNX2ly5ZT
Further company coverage: XRTX.V
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering